Silber RE et al. |
Comparison of the effect of FK 506 and alpha/beta-T-cell antibody R73 on transplant vascular sclerosis after heterotopic rat heart transplantation. |
1998 |
Transplant. Proc. |
pmid:9636398
|
Krüger B et al. |
Different effects of cyclosporine or tacrolimus on hepatocyte acute phase proteins. |
1998 |
Transplant. Proc. |
pmid:9636399
|
McAlister VC |
Liposomal tacrolimus: drug migration within blood compartments. |
1998 |
Transplant. Proc. |
pmid:9636404
|
Isobe M et al. |
Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase. |
1998 |
Transplant. Proc. |
pmid:9636407
|
Fujimura T et al. |
Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636413
|
Yoshimura N et al. |
Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636415
|
Yura H et al. |
Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636416
|
Chen H et al. |
FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse. |
1998 |
Transplant. Proc. |
pmid:9636419
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Miki T et al. |
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9636444
|
Kobashigawa JA |
Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine. |
1998 |
Transplant. Proc. |
pmid:9636445
|
Rieber J et al. |
Effects of tacrolimus and cyclosporine on the coronary microcirculation after heart transplantation: a prospective study with serial intracoronary flow measurements. |
1998 |
Transplant. Proc. |
pmid:9636446
|
Undre NA et al. |
Pharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636451
|
Walker RE et al. |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. |
1998 |
Transplant. Proc. |
pmid:9636452
|
Stempfle HU et al. |
Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636459
|
Marcus N et al. |
Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636460
|
Fritsche L et al. |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. |
1998 |
Transplant. Proc. |
pmid:9636481
|
Miura S et al. |
Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion. |
1998 |
Transplant. Proc. |
pmid:9636492
|
Preston R et al. |
FK 506 as primary immunosuppressive therapy in renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636493
|
Jensik SC |
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636494
|
Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Braun F et al. |
Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636496
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Morris-Stiff G et al. |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636499
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Turner CD et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. |
1998 |
Transplant. Proc. |
pmid:9636501
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|
Friemann S et al. |
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636504
|
Fernando ON et al. |
Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636505
|
Morris-Stiff G et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with chronic graft nephropathy: preliminary report. |
1998 |
Transplant. Proc. |
pmid:9636506
|
Busque S et al. |
Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. |
1998 |
Transplant. Proc. |
pmid:9636507
|
Loss GE et al. |
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. |
1998 |
Transplant. Proc. |
pmid:9636508
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|
Copley JB et al. |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. |
1998 |
Transplant. Proc. |
pmid:9636510
|
Jordan ML et al. |
Tacrolimus for rescue of refractory renal allograft rejection. |
1998 |
Transplant. Proc. |
pmid:9636511
|
Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
van Duijnhoven E et al. |
Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data. |
1998 |
Transplant. Proc. |
pmid:9636514
|
van Duijnhoven E et al. |
The effect of breakfast on the oral bioavailability of tacrolimus in diabetic and nondiabetic patients before transplantation. |
1998 |
Transplant. Proc. |
pmid:9636515
|
Christiaans M et al. |
Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636516
|
Sato S et al. |
Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636517
|
Uchida K et al. |
Decreasing pancreatic toxicity of tacrolimus by dosage reduction. |
1998 |
Transplant. Proc. |
pmid:9636518
|
Rostaing L et al. |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy. |
1998 |
Transplant. Proc. |
pmid:9636519
|
Rostaing L et al. |
Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636520
|
Morris-Stiff G et al. |
Pharmaco-economic study of FK 506 (Prograf) and cyclosporine A Neoral in cadaveric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9636521
|
Mendez R |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636522
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Claesson K et al. |
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients. |
1998 |
Transplant. Proc. |
pmid:9636524
|
Morris-Stiff G et al. |
Prospective randomized study comparing FK 506 (Prograft) and cyclosporine A (Neoral) as primary immunosuppression in cadaveric renal transplants at a single institution: interim report of the first 80 cases. |
1998 |
Transplant. Proc. |
pmid:9636525
|
Woodle ES et al. |
Meta-analysis of FK 506 and mycophenolate mofetil refractory rejection trials in renal transplantation. Refractory Rejection Meta-Analysis Study Group. |
1998 |
Transplant. Proc. |
pmid:9636526
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Kumar MS et al. |
ATGAM versus OKT3 induction therapy in cadaveric kidney transplantation: patient and graft survival, CD3 subset, infection, and cost analysis. |
1998 |
Transplant. Proc. |
pmid:9636549
|
Neylan JF |
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636551
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Wiesner RH |
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. |
1998 |
Transplant. Proc. |
pmid:9636565
|
Van Buren D et al. |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). |
1998 |
Transplant. Proc. |
pmid:9636566
|
Jain A et al. |
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. |
1998 |
Transplant. Proc. |
pmid:9636567
|
Zervos XA et al. |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636568
|
Millis JM et al. |
Successful use of tacrolimus for initial rejection episodes after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636569
|
Platz KP et al. |
FK506 for primary and rescue therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636570
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Cai TH et al. |
Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636572
|
Ringe B et al. |
Tacrolimus and mycophenolate mofetil in clinical liver transplantation: experience with a steroid-sparing concept. |
1998 |
Transplant. Proc. |
pmid:9636573
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results. |
1998 |
Transplant. Proc. |
pmid:9636575
|
Bilbao I et al. |
Experience with neoral cyclosporine through the oral route in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636580
|
Langrehr JM et al. |
Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636583
|
Abe M et al. |
Successful prednisone withdrawal after living-related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636584
|
Klupp J et al. |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636585
|
Steinmueller T et al. |
Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique. |
1998 |
Transplant. Proc. |
pmid:9636589
|
Liu WT et al. |
In vitro generation of tacrolimus metabolites and their detection in whole blood. |
1998 |
Transplant. Proc. |
pmid:9636590
|
Bekersky I et al. |
Bioequivalence of a new strength tacrolimus capsule under development. |
1998 |
Transplant. Proc. |
pmid:9636591
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Mueller AR et al. |
Does initial graft function influence the outcome after liver transplantation? |
1998 |
Transplant. Proc. |
pmid:9636594
|
Lang M et al. |
Impact of immunosuppression in liver transplantation across a positive crossmatch. |
1998 |
Transplant. Proc. |
pmid:9636595
|
Platz KP et al. |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636596
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Charco R et al. |
Hypercholesterolemia in long-term survivors of liver transplantation: a comparison between cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636605
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
McAlister VC et al. |
Cost of liver transplantation using tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636611
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
Wiebe K et al. |
FK506 rescue therapy in lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636613
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Ciancio G et al. |
Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636624
|
Bruce DS et al. |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636625
|
Peddi VR et al. |
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636626
|
Burke GW et al. |
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. |
1998 |
Transplant. Proc. |
pmid:9636627
|
Gruessner RW |
Antibody induction therapy in pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636632
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|